Replies to post #70203 on Amarantus Bioscience Holdings Inc (AMBS)

[L1ving]

Given an estimated ~390 million share count, that equates to a target price of $0.24 per share. I expect the value of Amarantus to rise as investors become more familiar with LymPro and the company begins to generate the necessary data for a CLIA filing.